It was identified through a medicinal chemistry programme at the University of Texas Health Science Center as the lead NNMT inhibitor candidate among a series of 1-methylquinolinium analogues bearing primary amine substitutions, selected for its combination of high passive membrane permeability (confirmed in PAMPA assays), high active transport membrane permeability (confirmed in bidirectional Caco-2 cell assays), potent NNMT inhibitory activity, and high selectivity including confirmed absence of inhibitory effects on related SAM-dependent methyltransferases or enzymes in the NAD+ salvage pathway
The concentration of Vitamin D in breast milk does not respond proportionally to increased maternal intake, and there is conflicting evidence of the effects of maternal supplementation on Vitamin D levels in breast-fed infants
They are not intended to diagnose, treat, cure, or prevent any disease.
It is worth noting that whilst some improvement may be rapid, complete resolution of symptomsparticularly neurological onescan take months of regular treatment
Route Subcutaneous Published Dose Context Common research-context planning cites 300-500 mcg/day from a reconstituted vial
